Patents by Inventor Scott Bannan

Scott Bannan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Wound healing compositions and treatments
    Patent number: 9937197
    Abstract: This invention concerns improved methods, uses, and kits for treating chronic wounds through the administration of anti-connexin agents, particularly anti-connexin 43 antisense polynucleotides. The methods, uses, and kits of the invention are based on the surprising and unexpected discovery that chronic wounds that do not increase or decrease in size by more than a pre-determined amount during a pre-treatment phase are more amenable to successful treatment than wounds whose size varies outside the target range during the pre-treatment phase.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: April 10, 2018
    Assignee: CoDa Therapeutics, Inc.
    Inventors: Anthony Phillips, David Eisenbud, Scott Bannan, Grove Matsuoka, David Pool, Tracey Sunderland, Bradford Duft
  • TREATMENT OF RESISTANT LESIONS
    Publication number: 20170056468
    Abstract: Connexin protein modulation methods and compositions are provided for the healing of resistant lesions, including lesions on subjects with multiple venous leg ulcers or multiple diabetic foot ulcers, and other responder subjects. Also provided are kits and articles of manufacture comprising a connexin protein modulating agent, for example, a connexin 43 modulating agent for use in the healing of resistant lesions.
    Type: Application
    Filed: August 25, 2016
    Publication date: March 2, 2017
    Inventors: David EISENBUD, Anthony PHILLIPS, Scott BANNAN, Grove MATSUOKA, DUFT Bradford
  • WOUND HEALING COMPOSITIONS AND TREATMENTS
    Publication number: 20160339052
    Abstract: This invention concerns improved methods, uses, and kits for treating chronic wounds through the administration of anti-connexin agents, particularly anti-connexin 43 antisense polynucleotides. The methods, uses, and kits of the invention are based on the surprising and unexpected discovery that chronic wounds that do not increase or decrease in size by more than a pre-determined amount during a pre-treatment phase are more amenable to successful treatment than wounds whose size varies outside the target range during the pre-treatment phase.
    Type: Application
    Filed: March 21, 2016
    Publication date: November 24, 2016
    Inventors: Anthony PHILLIPS, David EISENBUD, Scott BANNAN, Grove MATSUOKA, David POOL, Tracey SUNDERLAND, Bradford DUFT
  • IMPROVED WOUND HEALING COMPOSITIONS AND TREATMENTS
    Publication number: 20160264977
    Abstract: This invention concerns improved methods, uses, and kits for treating chronic wounds through the administration of anti-connexin agents, particularly anti-connexin 43 antisense polynucleotides. The methods, uses, and kits of the invention are based on the surprising and unexpected discovery that chronic wounds that do not increase or decrease in size by more than a pre-determined amount during a pre-treatment phase are more amenable to successful treatment than wounds whose size varies outside the target range during the pre-treatment phase.
    Type: Application
    Filed: March 15, 2014
    Publication date: September 15, 2016
    Applicant: CoDa Therapeutics, Inc.
    Inventors: Anthony PHILLIPS, David EISENBUD, Scott BANNAN, David POOL, Grove MATSUOKA, Tracey SUNDERLAND, Bradford James DUFT
  • Wound healing compositions and treatments
    Patent number: 9290554
    Abstract: This invention concerns improved methods, uses, and kits for treating chronic wounds through the administration of anti-connexin agents, particularly anti-connexin 43 antisense polynucleotides. The methods, uses, and kits of the invention are based on the surprising and unexpected discovery that chronic wounds that do not increase or decrease in size by more than a pre-determined amount during a pre-treatment phase are more amenable to successful treatment than wounds whose size varies outside the target range during the pre-treatment phase.
    Type: Grant
    Filed: March 15, 2014
    Date of Patent: March 22, 2016
    Assignee: CoDa Technologies, Inc.
    Inventors: Anthony Phillips, David Eisenbud, Scott Bannan, David Pool, Grove Matsuoka, Tracey Sunderland, Bradford Duft
  • Wound healing compositions and treatments
    Patent number: 9156896
    Abstract: This invention concerns improved methods, uses, and kits for treating chronic wounds through the administration of anti-connexin agents, particularly anti-connexin 43 antisense polynucleotides. The methods, uses, and kits of the invention are based on the surprising and unexpected discovery that chronic wounds that do not increase or decrease in size by more than a pre-determined amount during a pre-treatment phase are more amenable to successful treatment than wounds whose size varies outside the target range during the pre-treatment phase.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: October 13, 2015
    Assignee: CoDa Therapeutics, Inc.
    Inventors: Anthony Phillips, David Eisenbud, Scott Bannan, David Pool, Grove Matsuoka, Tracey Sunderland, Bradford Duft
  • WOUND HEALING COMPOSITIONS AND TREATMENTS
    Publication number: 20140275209
    Abstract: This invention concerns improved methods, uses, and kits for treating chronic wounds through the administration of anti-connexin agents, particularly anti-connexin 43 antisense polynucleotides. The methods, uses, and kits of the invention are based on the surprising and unexpected discovery that chronic wounds that do not increase or decrease in size by more than a pre-determined amount during a pre-treatment phase are more amenable to successful treatment than wounds whose size varies outside the target range during the pre-treatment phase.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: CoDa THERAPEUTICS, INC.
    Inventors: Anthony Phillips, David Eisenbud, Scott Bannan, David Pool, Grove Matsuoka, Tracey Sunderland, Bradford Duft
  • WOUND HEALING COMPOSITIONS AND TREATMENTS
    Publication number: 20140275218
    Abstract: This invention concerns improved methods, uses, and kits for treating chronic wounds through the administration of anti-connexin agents, particularly anti-connexin 43 antisense polynucleotides. The methods, uses, and kits of the invention are based on the surprising and unexpected discovery that chronic wounds that do not increase or decrease in size by more than a pre-determined amount during a pre-treatment phase are more amenable to successful treatment than wounds whose size varies outside the target range during the pre-treatment phase.
    Type: Application
    Filed: March 15, 2014
    Publication date: September 18, 2014
    Applicant: CoDa Therapeutics, Inc.
    Inventors: Anthony PHILLIPS, David EISENBUD, Scott BANNAN, David POOL, Grove MATSUOKA, Tracey SUNDERLAND, Bradford DUFT